Developing differentiated, multifunctional immuno-oncology products Sponsor content September 2017 Developing differentiated, multifunctional immuno-oncology products Crescendo Biologics Sep 07, 2017
Sponsor content Oncology Developing differentiated, multifunctional immuno-oncology products Crescendo Biologics Sep 07, 2017
F-star to Present Encouraging Preclinical Data on Lead Bispecific Programme FS118 at Upcoming Conferences Sponsor content F-star to Present Encouraging Preclinical Data on Lead Bispecific Programme FS118 at Upcoming Conferences F-star Sep 20, 2016
Sponsor content September 2016 Applying a versatile, innovative platform to oncology Crescendo Biologics Sep 12, 2016
F-star Announces Collaborative Agreement with Denali Therapeutics Sponsor content F-star Announces Collaborative Agreement with Denali Therapeutics F-star Aug 30, 2016
F-star announces funding and collaboration extension with new Christian Doppler Lab for Innovative Immunotherapeutics Sponsor content F-star announces funding and collaboration extension with new Christian Doppler Lab for Innovative Immunotherapeutics F-star Jul 14, 2016
F-star announces an agreement with CMC Biologics for manufacture of mAb² ™ bispecific antibodies Sponsor content F-star announces an agreement with CMC Biologics for manufacture of mAb² ™ bispecific antibodies F-star Jun 07, 2016
F-star: Growing interest in bispecific antibodies drove facility upgrade Sponsor content F-star: Growing interest in bispecific antibodies drove facility upgrade F-star May 24, 2016
Sponsor content The University of Tokyo: leader in advancing innovation The University of Tokyo Nov 10, 2015
Sponsor content Global cancer leader partners with industry to advance therapies and prepare future biomedical workforce The University of Texas MD Anderson Cancer Center Nov 10, 2015
